Immunolab: Combining targeted real-world data with advanced analytics to generate evidence at scale in immunology

Real-world evidence (RWE) has traditionally been used by regulatory or payer authorities to inform disease burden, background risk, or conduct post-launch pharmacovigilance, but in recent years RWE has been increasingly used to inform regulatory decision-making. However, RWE data sources remain frag...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamelin, Bernard, Rowe, Paul, Molony, Cliona, Kruger, Mark, LoCasale, Robert, Khan, Asif H., Jacob-Nara, Juby, Jacob, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Allergy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668850/
https://www.ncbi.nlm.nih.gov/pubmed/36407087
http://dx.doi.org/10.3389/falgy.2022.951795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668850/
https://www.ncbi.nlm.nih.gov/pubmed/36407087
http://dx.doi.org/10.3389/falgy.2022.951795

Ejemplares similares